Treatment of Wounds Utilizing Light

This study has been terminated.
(Slow patients recruitment)
Sponsor:
Information provided by:
QRay Ltd.
ClinicalTrials.gov Identifier:
NCT00634868
First received: February 7, 2008
Last updated: June 9, 2011
Last verified: June 2011

February 7, 2008
June 9, 2011
August 2008
December 2010   (final data collection date for primary outcome measure)
The wound healing process [ Time Frame: 12 weeks ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00634868 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Treatment of Wounds Utilizing Light
Not Provided

The Qray device is emitting broad light energy that is intended for diabetic ulcer healing. The study is double blinded.

Not Provided
Interventional
Not Provided
Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Caregiver)
Primary Purpose: Treatment
Diabetic Ulcer
  • Other: Qray light therapy device
    The light is filtered from harmful UV and InfraRed light and only light at wavelight of 405nm until 1000nm is delivered.
  • Device: Qray light therapy device-Sham
    non curative light- the device emits the same broad light, but with very low intensity
  • Sham Comparator: 1
    The device is emitting a sham light
    Intervention: Device: Qray light therapy device-Sham
  • Experimental: 2
    The device is emitting curative light
    Intervention: Other: Qray light therapy device
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Terminated
30
December 2010
December 2010   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Patient has 8 weeks venus leg ulcer.
  • The ulcer was not better on prior treatment of various medical clinics.
  • The patient has diabetic ulcer grade 1 or 2

Exclusion Criteria:

  • Patient has severe infection.
  • Patient is taking antibiotic
  • Patient has ankle brachial index less than 0.7
  • Patient is schedule to undergone revascularization surgery 10 weeks before the study
  • Patient has photosensitive disease
  • Patient has cancer
  • Creatinine level is more than 2 mg%
  • Patient is taking immunosuppressive medication.
  • Pregnant women
  • Dialysis patient
  • Anaemic patients(less than 9 gr)
  • Patient has Albumin level less than 3 mg%
Both
18 Years to 80 Years
No
Contact information is only displayed when the study is recruiting subjects
Israel
 
NCT00634868
or003121107
Yes
Qray Ltd, Qray
QRay Ltd.
Not Provided
Not Provided
QRay Ltd.
June 2011

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP